NEU 1.20% $20.22 neuren pharmaceuticals limited

Yep, I agree! Unlike a lot of other bio's with multiple...

  1. 138 Posts.
    Yep, I agree! Unlike a lot of other bio's with multiple competitors in their space and current treatment options, Neuren really has a first mover advantage in this space too. Very exciting!

    All I am saying is that I'm not so sure the market is going to realise all that (or be willing to bet on it) off the results alone, even if they are clinically excellent. Maybe some years ago it would be enough, but I think in this present time the deals need to be well advanced. Just my interpretation and trying to keep my expectations in check so not to be disappointed if it doesn't fly. Hoping for the best for all of us holders and of course the patients suffering with these disorders.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$20.22
Change
0.240(1.20%)
Mkt cap ! $2.584B
Open High Low Value Volume
$20.11 $20.34 $19.63 $8.874M 441.3K

Buyers (Bids)

No. Vol. Price($)
1 1010 $20.22
 

Sellers (Offers)

Price($) Vol. No.
$20.23 1443 2
View Market Depth
Last trade - 16.10pm 25/06/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.